Safety and Efficacy of a Composite Lipid Emulsion with Fish Oil in Hospitalized Neonates and Infants Requiring Prolonged Parenteral Nutrition - A Randomized, Double-Blind, Multicenter, Controlled Trial

CO-ILE was associated with a possible lower risk of cholestasis and significantly lower conjugated bilirubin concentration at the end of the initial treatment phase in high-risk neonates and infants as compared with patients treated with SOLE. In summary, these data indicate that CO-ILE can be considered safe and may be preferable over SOLE in high-risk neonates. This trial was registered at clinicaltrials.gov as NCT02579265.

Authors

Institutions

Publication Details

Journal
Journal of Nutrition
Published
2024-10-05
DOI
https://doi.org/10.1016/j.tjnut.2024.10.005
Citations
2
Primary Topic
Clinical Nutrition and Gastroenterology
Type
article
Field-Weighted Citation Impact
0.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of a Composite Lipid Emulsion with Fish Oil in Hospitalized Neonates and Infants Requiring Prolonged Parenteral Nutrition - A Randomized, Double-Blind, Multicenter, Controlled Trial

Jeffrey A. Rudolph, Steven A. Abrams, Darla Shores, Katherine R. McCallie et al.
2 citations
Journal of Nutrition
Clinical Nutrition and Gastroenterology
0.62
article

Safety and Efficacy of a Composite Lipid Emulsion with Fish Oil in Hospitalized Neonates and Infants Requiring Prolonged Parenteral Nutrition - A Randomized, Double-Blind, Multicenter, Controlled Trial

Jeffrey A. Rudolph, Steven A. Abrams, Darla Shores, Katherine R. McCallie, Amy B. Hair, Daniel T. Robinson, Ann Anderson‐Berry, K Ernst, Joanne Lai, Jörn-Hendrik Weitkamp, Jaehwan Kim, Brian Lane, Orly Levit, Maria R. Mascarenhas, Con Yee Ling
article en
2 citations

Abstract

CO-ILE was associated with a possible lower risk of cholestasis and significantly lower conjugated bilirubin concentration at the end of the initial treatment phase in high-risk neonates and infants as compared with patients treated with SOLE. In summary, these data indicate that CO-ILE can be considered safe and may be preferable over SOLE in high-risk neonates. This trial was registered at clinicaltrials.gov as NCT02579265.

Journal of NutritionVol. 154(12)
Cincinnati Children's Hospital Medical Center (US), Yale New Haven Hospital (US), Primary Children's Hospital (US), Children's Hospital of Philadelphia (US), Johns Hopkins University (US), Palo Alto University (US), Johns Hopkins Medicine (US), Rady Children's Hospital-San Diego (US), Monroe Carell Jr. Children's Hospital (US), Children's Hospital of Oklahoma (US), Lurie Children's Hospital (US), Perinatal Institute (GB), Children's Hospital of Pittsburgh (US), Texas Children's Hospital (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Nebraska Medical Center (US), The University of Texas at Austin (US), Stanford University (US), Icahn School of Medicine at Mount Sinai (US)
Fresenius Kabi, U.S. Food and Drug Administration
Zero hunger
Openalex Percentile: Top 33%
Clinical Nutrition and Gastroenterology
0.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.